186 related articles for article (PubMed ID: 15718035)
1. Mean age of onset in familial Alzheimer's disease is determined by amyloid beta 42.
Duering M; Grimm MO; Grimm HS; Schröder J; Hartmann T
Neurobiol Aging; 2005 Jun; 26(6):785-8. PubMed ID: 15718035
[TBL] [Abstract][Full Text] [Related]
2. Presenilin 2 familial Alzheimer's disease mutations result in partial loss of function and dramatic changes in Abeta 42/40 ratios.
Walker ES; Martinez M; Brunkan AL; Goate A
J Neurochem; 2005 Jan; 92(2):294-301. PubMed ID: 15663477
[TBL] [Abstract][Full Text] [Related]
3. Decreased Abeta secretion by cells expressing familial Alzheimer's disease-linked mutant presenilin 1.
Shimojo M; Sahara N; Murayama M; Ichinose H; Takashima A
Neurosci Res; 2007 Mar; 57(3):446-53. PubMed ID: 17210196
[TBL] [Abstract][Full Text] [Related]
4. A novel presenilin-1 mutation: increased beta-amyloid and neurofibrillary changes.
Gómez-Isla T; Wasco W; Pettingell WP; Gurubhagavatula S; Schmidt SD; Jondro PD; McNamara M; Rodes LA; DiBlasi T; Growdon WB; Seubert P; Schenk D; Growdon JH; Hyman BT; Tanzi RE
Ann Neurol; 1997 Jun; 41(6):809-13. PubMed ID: 9189043
[TBL] [Abstract][Full Text] [Related]
5. Mean age-of-onset of familial alzheimer disease caused by presenilin mutations correlates with both increased Abeta42 and decreased Abeta40.
Kumar-Singh S; Theuns J; Van Broeck B; Pirici D; Vennekens K; Corsmit E; Cruts M; Dermaut B; Wang R; Van Broeckhoven C
Hum Mutat; 2006 Jul; 27(7):686-95. PubMed ID: 16752394
[TBL] [Abstract][Full Text] [Related]
6. Presenilins and Alzheimer's disease: the role of A beta 42.
Eckman CB
J Neural Transm Suppl; 1998; 53():181-4. PubMed ID: 9700656
[TBL] [Abstract][Full Text] [Related]
7. Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1.
Duff K; Eckman C; Zehr C; Yu X; Prada CM; Perez-tur J; Hutton M; Buee L; Harigaya Y; Yager D; Morgan D; Gordon MN; Holcomb L; Refolo L; Zenk B; Hardy J; Younkin S
Nature; 1996 Oct; 383(6602):710-3. PubMed ID: 8878479
[TBL] [Abstract][Full Text] [Related]
8. Familial Alzheimer's disease mutations inhibit gamma-secretase-mediated liberation of beta-amyloid precursor protein carboxy-terminal fragment.
Wiley JC; Hudson M; Kanning KC; Schecterson LC; Bothwell M
J Neurochem; 2005 Sep; 94(5):1189-201. PubMed ID: 15992373
[TBL] [Abstract][Full Text] [Related]
9. Novel aspects of accumulation dynamics and A beta composition in transgenic models of AD.
Lewis HD; Beher D; Smith D; Hewson L; Cookson N; Reynolds DS; Dawson GR; Jiang M; Van der Ploeg LH; Qian S; Rosahl TW; Kalaria RN; Shearman MS
Neurobiol Aging; 2004 Oct; 25(9):1175-85. PubMed ID: 15312963
[TBL] [Abstract][Full Text] [Related]
10. The presenilin 1 C92S mutation increases abeta 42 production.
Lewis PA; Perez-Tur J; Golde TE; Hardy J
Biochem Biophys Res Commun; 2000 Oct; 277(1):261-3. PubMed ID: 11027672
[TBL] [Abstract][Full Text] [Related]
11. Cytoskeletal alterations differentiate presenilin-1 and sporadic Alzheimer's disease.
Woodhouse A; Shepherd CE; Sokolova A; Carroll VL; King AE; Halliday GM; Dickson TC; Vickers JC
Acta Neuropathol; 2009 Jan; 117(1):19-29. PubMed ID: 19015863
[TBL] [Abstract][Full Text] [Related]
12. Evidence that Abeta42 plasma levels in presenilin-1 mutation carriers do not allow for prediction of their clinical phenotype.
De Jonghe C; Cras P; Vanderstichele H; Cruts M; Vanderhoeven I; Smouts I; Vanmechelen E; Martin JJ; Hendriks L; Van Broeckhoven C
Neurobiol Dis; 1999 Aug; 6(4):280-7. PubMed ID: 10448055
[TBL] [Abstract][Full Text] [Related]
13. Heritability of plasma amyloid beta in typical late-onset Alzheimer's disease pedigrees.
Ertekin-Taner N; Graff-Radford N; Younkin LH; Eckman C; Adamson J; Schaid DJ; Blangero J; Hutton M; Younkin SG
Genet Epidemiol; 2001 Jul; 21(1):19-30. PubMed ID: 11443731
[TBL] [Abstract][Full Text] [Related]
14. The presenilin-1 familial Alzheimer disease mutant P117L impairs neurogenesis in the hippocampus of adult mice.
Wen PH; Hof PR; Chen X; Gluck K; Austin G; Younkin SG; Younkin LH; DeGasperi R; Gama Sosa MA; Robakis NK; Haroutunian V; Elder GA
Exp Neurol; 2004 Aug; 188(2):224-37. PubMed ID: 15246822
[TBL] [Abstract][Full Text] [Related]
15. Presenilins and early-onset familial Alzheimer's disease.
Rohan de Silva HA; Patel AJ
Neuroreport; 1997 May; 8(8):i-xii. PubMed ID: 9223053
[TBL] [Abstract][Full Text] [Related]
16. Novel presenilin 1 mutation (S170F) causing Alzheimer disease with Lewy bodies in the third decade of life.
Snider BJ; Norton J; Coats MA; Chakraverty S; Hou CE; Jervis R; Lendon CL; Goate AM; McKeel DW; Morris JC
Arch Neurol; 2005 Dec; 62(12):1821-30. PubMed ID: 16344340
[TBL] [Abstract][Full Text] [Related]
17. Familial Alzheimer's disease: site of mutation influences clinical phenotype.
Lippa CF; Swearer JM; Kane KJ; Nochlin D; Bird TD; Ghetti B; Nee LE; St George-Hyslop P; Pollen DA; Drachman DA
Ann Neurol; 2000 Sep; 48(3):376-9. PubMed ID: 10976645
[TBL] [Abstract][Full Text] [Related]
18. [Detection of antibodies to beta-amyloid in carriers of E280A mutation in the presenilin-1 gene].
Toro F; Lopera F; Ossa J; Madrigal L; Mira A; Díaz A; Parra S
Rev Neurol; 1999 Dec 16-31; 29(12):1104-7. PubMed ID: 10652730
[TBL] [Abstract][Full Text] [Related]
19. [Genetic factors in the pathogenesis of Alzheimer's disease: roles of beta-amyloid and presenilins].
Iwatsubo T; Tomita T
Tanpakushitsu Kakusan Koso; 1998 Oct; 43(13):1963-72. PubMed ID: 9789459
[No Abstract] [Full Text] [Related]
20. Differences in regional brain atrophy in genetic forms of Alzheimer's disease.
Gregory GC; Macdonald V; Schofield PR; Kril JJ; Halliday GM
Neurobiol Aging; 2006 Mar; 27(3):387-93. PubMed ID: 15894410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
